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Migrant Farm Workers Recommendations of the
Advisory Council for the Elimination of
Tuberculosis * 
Summary 
Farm workers are approximately six times more likely to develop tuberculosis (TB) than the general
population of employed adults. These recommendations are presented to assist health-care providers
serving migrant and seasonal farm workers. The following services, listed by priority, that should be
available for migrant and seasonal farm workers and their family members are: a) detection and diagnosis
of those with current symptoms of active TB; b) appropriate treatment and monitoring for those who have
current disease; c) contact investigation and appropriate preventive therapy for those exposed to infectious
persons; d) screening and appropriate preventive therapy for asymptomatically infected workers who may
be immunosuppressed, such as those with human immunodeficiency virus (HIV) infection; e) screening
and appropriate preventive therapy for children of migrant and seasonal farm workers; and f) widespread
tuberculin test screening for workers and families with preventive therapy prescribed, as appropriate.
Health-care providers should immediately perform appropriate diagnostic studies for persons with a
productive, prolonged cough, or other symptoms suggestive of tuberculosis. Health departments should be
immediately notified when TB is suspected or diagnosed to enable examination of contacts and initiation
of other health department diagnostic, preventive, or patient management services. 
Workers and family members with uncomplicated pulmonary TB should be treated with a regimen that
includes isoniazid, rifampin, pyrazinamide, and ethambutol (or streptomycin). Drug-resistant TB is an
important consideration since it requires altered treatment regimes and because higher rates of resistance
have been found in ethnic and social groups comprising much of the migrant farm worker-force. Patients
should be monitored carefully for compliance, treatment response, and toxicity. Ideally, patients should be
placed on directly observed therapy given by a well-trained, outreach worker from the same
cultural/language background as the patients. 
INTRODUCTION 
The Department of Health and Human Services (DHHS) Advisory Council for the Elimination of
Tuberculosis (ACET) has published a plan for the elimination of tuberculosis (TB) from the United States
by the Year 2010 (1). The plan gives top priority to implementation of strategies to prevent TB in
identifiable high-incidence population groups, including migrant and seasonal farm workers. In this
document, a "migrant farm worker" is defined as a laborer whose principal employment is in agriculture
on a seasonal basis and who establishes for the purposes of such employment a temporary abode. The term
"seasonal farm worker" means a person whose principal employment is in agriculture on a seasonal basis,
but who does not move from area to area for work. 
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These recommendations are intended for health-care providers serving migrant and seasonal farm workers
-- providers who can contribute to the elimination of TB in this population through improved screening,
prevention, and control activities. The recommendations are also directed to health departments because
of their important role in assisting migrant health-care providers in the prevention and control of TB
among migrant and seasonal farm workers. Finally, these recommendations are directed to public policy
and decision makers because many health departments and migrant health-care providers do not now have
the resources and staff to fully implement these recommendations. 
MIGRANT FARM WORKERS AND MIGRANT PATTERNS 
Information provided by the Office of Migrant Health, DHHS, indicates that there are an estimated 4.2
million migrant and seasonal farm workers in the United States. Approximately 500,000 (12%) are served
by federally supported migrant health centers (2). Compared with the general population, these workers
often have numerous and complex health problems (e.g., TB, parasitic diseases, other communicable
diseases, diabetes, hypertension, high-risk pregnancy, and neonatal problems), and they often live in
substandard housing and in very crowded conditions. Continuity of medical care is difficult for migrant
farm workers because they move often. Migrant and seasonal farm workers and their families often face
linguistic, cultural, financial, immigration, educational, and other barriers that also make it difficult for
them to obtain needed health-care services. 
These barriers must be addressed by migrant health and public health officials when designing and
carrying out strategies for implementing the recommendations in this report. 
Migrant farm workers in the United States traditionally follow one of three geographic migratory streams
(travel patterns: East Coast, Midwest, and West Coast). The race, ethnicity, and cultural background of
migrant farm workers vary somewhat from stream to stream. Living and working conditions, as well as
access to transportation, also vary. These differing characteristics may affect access to health-care and the
formulation of strategies for TB prevention and control. In all three streams, families often migrate
together to maximize family income. Some settle in a town to pursue better educational or work
opportunities, but often remain tied to local agricultural activities. 
The primary residence or homebase areas (e.g., California, Texas, Puerto Rico, and Florida) for all three
streams are economically disadvantaged areas. 
East Coast Migrant Stream 
In the East Coast stream, most workers have their primary homebase, or winter home, in southern Florida.
The largest cultural groups in this stream are Hispanic, primarily Mexican Americans and Mexicans,
Central American refugees, and Puerto Ricans; other groups in this stream are American blacks, Haitians
and Appalachian whites. 
Migrants in the East Coast stream most often reside in ethnically homogeneous labor camps, characterized
by family unit housing or single-sex barracks. A primary contractor or crew leader usually contracts
directly with a grower to supply farm workers. The crew leader also provides meals and transportation, the
cost of which is usually deducted from workers' pay. Farm workers, during the harvest season, may change
camps or move to a new location with a crew or group. Thus, outreach is a very important factor in
delivering health care to this migrant population. 
Midwest Migrant Stream 
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In the Midwest stream, most farm workers use south Texas as their homebase and work winter crops there
before moving up into the midwestern states. South Texas is the largest migrant homebase area in the
nation. Migrant farm workers from there also may move into the East and West Coast migrant streams.
Mexican Americans constitute the majority of migrant farm workers in this stream, but recently the
number of Southeast Asian migrant farm workers has been increasing in this stream. 
The basic Midwest migrant family unit travels "upstream" from the homebase community in groups with
children and other relatives, sometimes also accompanied by friends, including single males. The migrant
groups generally travel in cars with the crew leader or "truckero" transporting personal possessions in a
truck for the crew. The crew leader's truck also may be used to haul produce during harvesting. 
Migrants in southern Texas live as part of the community in "colonias" or unincorporated areas. These
areas are not required to have water, sewage, or electric services, and some colonias have none. Three to
six families may live under one roof on a 20' by 40' plot of land. Family members cross the border to visit
or stay with relatives in Mexico during the winter months. When not in the homebase area, migrants in the
Midwest stream live primarily in labor camps. 
West Coast Migrant Stream 
Most migrant farm workers in the West Coast stream use southern California as homebase. This stream
runs north through Idaho, Oregon, and Washington. The West Coast stream consists mostly of Mexican
Americans from the southwest, primarily California and Texas. American blacks, non-Hispanic whites,
and increasing numbers of Southeast Asians and Central Americans comprise a smaller percentage of the
migrant farm workers in this stream. Southeast Asians, however, quickly settle in the area, leaving the
migrant stream. 
The primary migrant units in the West Coast Stream are individual families. Some single males come from
Mexico to work the crops and then return home. Many of these workers own their own cars and have more
mobility and better access to medical care. 
Generally, there are better housing conditions in the West Coast stream than in the other streams.
However, migrants are living under bridges and along river banks in Southern California. As in other
migrant streams, these migrant families live in labor camps when they leave their homebase. 
TUBERCULOSIS IN MIGRANT FARM WORKERS 
Although the magnitude of the problem of TB among migrant and seasonal farm workers is not clearly
established, a survey conducted by CDC during the period 1985-1989 assessed the occupational and
residential characteristics of TB cases reported in 29 states; overall farm workers accounted for more than
5% of all employed cases. Based on data from that survey, the risk of TB among farm workers was
estimated to be six times greater than the general population of employed adults (CDC, unpublished data).
The first population-based study of TB in a random sample of migrant farm workers, conducted in 1988 in
North Carolina, indicated a prevalence of active TB in 0.47% of Hispanics and 3.5% of American blacks
(3). 
Migrant farm workers also have high rates of asymptomatic TB infection (positive skin tests). A 1987
study showed a skin-test positivity rate of 29% among U.S.-born blacks and 55% among Haitian migrant
farm workers in the Delmarva Peninsula (4). Tuberculin testing of migrant farm workers employed in
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Virginia's Eastern Shore showed overall skin-test positivity rates of 39% and 48% in 1984 and 1985,
respectively (5). In a separate study conducted in 1988, Hispanic migrant farm workers in North Carolina
had a tuberculin skin-test positivity rate of 31% (6). A 1988 study demonstrated a 47% prevalence rate of
TB infection among migrant farm workers 15-34 years of age and a 68% prevalence rate among those
greater than 34 years of age (7). In the population-based study (3), tuberculin positivity rates ranged from
33% (Hispanics) to 62% (blacks) to 76% (Haitians). These high rates of asymptomatic TB infection
suggest that screening and prevention activities should be directed to migrant farm workers. 
INFECTION AND TRANSMISSION 
The TB organism M. tuberculosis, also known as the tubercle bacillus, is transmitted primarily through
the air from persons with TB of the lung who are coughing. Persons who share the same air with an
infectious person for long periods of time are at risk of becoming infected. This includes persons living in
the same household with the infectious person and those who travel in the same vehicle. Most persons
who become infected usually develop a positive TB skin test, but remain asymptomatic and are not
infectious. The lifetime risk of acquiring clinically active TB disease is about 10%; it is greatest in the first
2 years after infection, but disease can also occur many years later. Impairment of the immune system,
such as by HIV infection, increases the risk of clinically active TB. 
RECOMMENDATIONS 
ACET developed these recommendations for the Public Health Service, public health departments, and
for health-care providers serving migrant and seasonal farm workers. 
Prevention and Control 
The following prevention and control activities should be undertaken for all migrant and seasonal farm
workers and their families. 
The services of highest priority that should be available to all workers and their families, are: 
Detection and diagnosis of those persons with current symptoms of active TB. 
Appropriate treatment for those persons with disease. 
Contact investigation and appropriate preventive therapy for those persons exposed to
infectious (sputum positive) TB. 
Screening and appropriate preventive therapy for workers who may be immunosuppressed,
including those with HIV infection. 
The second priority is screening and appropriate preventive therapy for children of migrant and
seasonal farm workers. 
The third priority is widespread tuberculin skin-test screening of workers and families, followed by
appropriate preventive therapy. 
Providing the above services will require a commitment of resources from the national, state, and local
levels. 
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Diagnosis 
Pulmonary TB should be suspected in persons with a productive, prolonged cough ( greater than 2
weeks in duration). Other common symptoms of TB include fever, chills, night sweats, fatigue, loss
of appetite, weight loss, and, occasionally, hemoptysis (coughing up blood). 
Persons with suspected pulmonary TB should receive an immediate evaluation that includes: a
medical history and physical examination, chest x-ray, Mantoux tuberculin test, at least three
sputum specimens (collected on separate days) for acid fast bacilli (AFB) smear, culture and drug
susceptibility testing, and HIV-antibody counseling and testing. 
If the clinician confirms or suspects TB as a result of this examination, the local health department
should be notified so that appropriate examination of contacts can be initiated. Migrant health-care
providers should seek, and health departments should provide, no-cost TB medical consultation,
medication and laboratory services for migrant farm workers. 
Hospitalization and Isolation 
Health departments should ensure that inpatient care (e.g., hospitalization) is available at no cost to
migrant farm workers or family members. Persons hospitalized with infectious TB should be placed
in AFB isolation until they become noninfectious (8). 
Health department TB control staff should be consulted on issues regarding hospitalization,
housing, and return to work. The restriction of normal activities and the duration of such restrictions
depends upon: the degree of infectiousness, the response to treatment, the nature of activities, and
the likelihood that others might be exposed. Some patients are never infectious and have no need
for restrictions. Care must be taken in housing TB patients to ensure that those who may be
infectious do not expose uninfected farm workers or family members. Patients who feel well may be
able to continue normal work activities, particularly in an open-air work setting where there is little
risk of exposure for new or highly susceptible contacts. 
Treatment (Tables 1 and 2) 
Migrant and seasonal farm workers and family members with uncomplicated pulmonary TB can be
treated with the following 6- month regimen: isoniazid, rifampin, pyrazinamide, and ethambutol (or
streptomycin) given for 2 months (initial phase), followed by isoniazid and rifampin for 4 months
(second phase). Ethambutol (or streptomycin) should be included in the initial regimen until drug
susceptibility studies are available. Among migrant workers, higher rates of resistance to isoniazid
and streptomycin are known to occur. Drug resistance is also more common in patients with a
history of previous treatment and in contacts to drug-resistant patients. 
Medication does not have to be given on a daily basis throughout the entire course of treatment.
Several options exist for administering directly observed therapy. Intermittent (e.g., twice weekly)
therapy may be administered during the second phase after daily therapy during the initial phase.
For those for whom prolonged supervision of daily therapy during the initial phase is impractical, a
regimen of daily isoniazid, rifampin, pyrazinamide, and ethambutol (or streptomycin) for 2 weeks,
followed by twice weekly administration of the same drugs for 6 weeks, and subsequently twice
weekly isoniazid and rifampin for 16 weeks has been shown to be highly effective (9). Alternatively,
three times weekly administration of isoniazid, rifampin, pyrazinamide, and ethambutol (or
streptomycin) for 6 months yields equivalent results (10). (When isoniazid, ethambutol, and
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pyrazinamide are administered 2 or 3 times weekly instead of every day, the dosage must be
increased; the rifampin dose is the same for daily or intermittent therapy.) 
In cases of smear and culture negative pulmonary TB, when drug resistance is unlikely, reducing the
6-month regimen to 4 months is acceptable. The same regimen should be used to treat
sputum-culture-negative, tuberculin-positive persons with radiographic evidence of healed TB or silicosis.
All persons with confirmed or suspected TB should be offered HIV testing and counseling. For HIV
seropositive patients, treatment should be continued for a minimum of 9 months and for at least 6
months beyond documented culture conversion as evidenced by three negative cultures. 
Patients treated with rifampin who are on methadone should have the methadone dosage increased
to avoid withdrawal symptoms resulting from the interaction between the two drugs (11). 
The treatment regimen should be appropriately revised if resistance to any of the drugs in the
regimen is found. 
Treatment of extrapulmonary TB and TB related to drug resistance or HIV infection may be
complicated. For this reason, a health department or another qualified TB and infectious disease
medical expert should be consulted. 
Monitoring Response (Table 3) 
Patients should be medically assessed at least twice monthly for symptoms and by smear until they
become asymptomatic and smear negative. Cultures should be obtained at least monthly until
negative. Frequent smears and cultures are the most reliable means for detecting treatment failure.
Treatment failure is often due to patient noncompliance with therapy, but also may be due to an
ineffective regimen (e.g., when the organisms are resistant to the drugs). 
Patients should demonstrate sputum conversion within 3 months. Appropriate medical consultation
should be sought for patients whose sputum does not convert within this time. Such patients must
be evaluated for noncompliance and drug-resistant organisms. 
Toxicity monitoring must be individualized and based on the drugs used in a given regimen and
patient factors related to toxicity (e.g., age and alcohol use). Patients should be evaluated at least
monthly during therapy and questioned about reactions to determine toxicity, even if no problems
are apparent. Patients should be specifically instructed to look for symptoms associated with the
most common reactions to the medications they are receiving. If symptoms suggesting drug toxicity
occur, appropriate laboratory testing and medical evaluation should be performed immediately. 
All patients receiving isoniazid, rifampin, and/or pyrazinamide should be instructed to report
immediately any symptoms suggesting hepatitis (loss of appetite, nausea, vomiting, jaundice,
malaise, unexplained elevated temperature of greater than 3 days duration, or abdominal
tenderness). 
Peripheral neuropathy associated with isoniazid administration is uncommon at doses of 5 mg/kg.
Among persons with conditions in which neuropathy is common (diabetes, uremia, alcoholism,
malnutrition), pyridoxine (50 mg day) may be given with isoniazid. It is also advisable to give
pyridoxine with isoniazid to pregnant women or persons who have a seizure disorder. 
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Hyperuricemia may occur in patients receiving pyrazinamide, but acute gout is uncommon. 
The interaction of isoniazid and phenytoin increases the serum concentration of both drugs. When
these drugs are given concomitantly, the serum level of phenytoin should be monitored. 
Rifampin may accelerate clearance of drugs metabolized by the liver. These include methadone,
coumadin derivatives, glucocorticoids, estrogens, oral hypoglycemic agents, digitalis,
anticonvulsants, ketoconazole, and cyclosporin. By accelerating estrogen metabolism, rifampin may
interfere with the effectiveness of oral contraceptives. 
Outreach workers responsible for directly observed therapy should be trained to identify symptoms
related to reactions and toxicity. They should also be trained to obtain sputum specimens. 
Monitoring Compliance 
Treatment must be continuous to be effective. Identify noncompliance early, before drug resistance,
treatment failure, or relapse occurs, or before the patient is lost to follow-up. 
A number of techniques have been developed to assist in identifying the noncompliant patient. The
majority of noncompliant patients is determined by their failure to return for follow-up clinic visits.
Thus, having an accurate appointment and delinquent referral system is paramount. An effective
communication system is also needed to assure that the discovery of missed appointments
immediately comes to the attention of the responsible public health officials. Monthly pill counts
are also helpful in early identification of noncompliance. 
The best way to ensure compliance is to place patients on directly observed therapy given by a
well-trained outreach worker from the same cultural/language background as the patient population.
Health departments should provide staff for this purpose. As an alternative, a concerned and
interested person may be identified to directly observe the patient's therapy (e.g., family member). 
Incentives and enablers should be considered to encourage patient compliance. These might include
such items as food or food vouchers and transportation vouchers or tokens. 
Long-term institutionalization is sometimes necessary for the management of seriously
uncooperative patients. If, despite the best efforts of migrant health-care and health department staff,
an infectious patient refuses treatment, temporary involuntary isolation may be mecessary in
accordance with state and local public health laws and regulations. This option should be used only
in rare instances and only after due process. 
Contact Investigation 
Contact investigation should begin as soon as a migrant or seasonal farm worker or family member
is suspected to have infectious TB. The health department assumes this responsibility. The
investigation normally involves a visit to the patient's work and housing site to observe transmission
possibilities, identify contacts, and to note factors that might affect compliance with treatment or
preventive therapy. 
The investigation should begin with close contacts who are most likely to be infected, usually the
persons living with and sharing the same air space as the patient. Close contacts include family
members of workers traveling and working alone, if they have lived in the household during the
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preceding year. (The health department can make arrangements to ensure that out-of-area family
members and other remote contacts receive appropriate examinations.) 
High priority should be given to rapid examination of close contacts who are children. Newly
infected children can develop life threatening meningitis within weeks of infection unless
preventive therapy is administered. 
Contacts should be interviewed for symptoms and given a tuberculin skin-test using the Mantoux
technique. Those with symptoms of respiratory disease or skin-test reactions of greater than or equal
to 5mm should be given chest radiograph examinations. All contacts with reactions of greater than
or equal to 5mm should be considered for preventive therapy. Close contacts of highly infectious
persons, especially young children, should be considered for preventive therapy even if the initial
tuberculin test after exposure is negative. The preventive therapy can be halted if contact with the
infectious person(s) is discontinued and a repeat tuberculin test, 3 months after exposure, remains
negative. 
Screening 
Screening should be carried out by migrant health-care providers in cooperation with employers and
local health departments. In the absence of definitive data, screening of migrant farm workers
should be considered annually. 
Emphasis should be placed on screening and preventive therapy conducted in the homebase sites.
However, since access to health care is sometimes better in non-homebase areas, TB screening and
preventive therapy programs should be encouraged wherever resources and access to migrant farm
workers permit. This is particularly important for "settled out" workers who choose not to return to
homebase areas. 
The Mantoux tuberculin skin test should be used to identify persons who have been infected with
M. tuberculosis. Multiple puncture tests should not be used. Migrant and seasonal farm workers, as
well as members of their families, should be considered tuberculin positive according to the
following criteria. Outside the United States, many countries use Bacille Calmette-Guerin (BCG)
vaccination as part of their TB control activities, especially for infants. The degree of sensitivity to
tuberculin that is acquired after BCG vaccination is highly variable. No reliable method exists for
distinguishing tuberculin reactions caused by previous BCG vaccination from those caused by
natural mycobacterial infections. Positive tuberculin reactions in BCG-vaccinated persons from
high prevalence areas usually indicate infection with M. tuberculosis. Such persons should be
evaluated for preventive therapy. 
Persons who have tuberculous infection should receive a chest radiograph. If the radiograph does not
show TB, preventive therapy should be considered. Persons with abnormal radiographs and/or other
symptoms suggesting TB should be referred for further evaluation. 
Preventive Therapy 
The use of preventive therapy can substantially reduce the risk of TB (by more than 90%) in
infected persons who comply with therapy (12). A minimum of 6 months of preventive therapy is
recommended. However, a 12-month course is recommended for tuberculin-positive persons with
HIV infection. 
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Whenever necessary, preventive therapy should be directly observed and should be administered
twice weekly to facilitate the supervision of treatment (INH 15mg/kg up to 900mg). 
Before migrant farm workers and their family members are placed on preventive therapy, ensure that
they are likely to complete at least 6 months of the regimen. The rationale for this policy is to ensure
that persons receive the benefits from 6 months of preventive therapy and not just the early risk of
toxicity. Persons with a positive tuberculin reaction who are not placed on preventive therapy
should be counseled about the meaning of the skin-test reaction and instructed to seek medical
attention if they develop symptoms suggesting TB. 
The following list defines those migrant and seasonal farm workers and their family members with
positive tuberculin reactions (who have not been previously treated) who should be considered
candidates for preventive therapy regardless of age: 
Persons with known or suspected HIV infection, including injecting drug users. 
Close contacts of infectious persons. 
Recent tuberculin skin test converters (defined as a greater than or equal to 10 mm increase
for those less than 35 years old; or a greater than or equal to 15 mm increase for those greater
than or equal to 35 years old). 
Persons with medical conditions that increase the risk of TB (e.g., diabetes, being 10% or
more below ideal body weight, or prolonged adrenocorticosteroid therapy). 
Persons with a positive tuberculin test should be considered for preventive therapy even if they have
no other medical risk factor when they are less than 35 years of age. 
Before therapy is initiated, baseline liver function studies should be done for all persons greater than
or equal to 35 years of age. 
Persons on preventive therapy should be monitored at least monthly, by questioning, for:
compliance with prescribed regimen, symptoms of neurotoxicity (such as paresthesia of hands or
feet), and signs consistent with hepatotoxicity (e.g., loss of appetite, nausea, vomiting, persistent
dark urine, jaundice, malaise, or unexplained elevated temperature of greater than 3 days duration,
or abdominal tenderness especially in the upper right quadrant). Patients should be advised to report
immediately to their health-care provider if any of these signs or symptoms occur. 
Pill counts should be done each month for all persons on preventive therapy. 
Follow-Up 
When a migrant farm worker is departing and requires treatment for active TB, preventive
treatment, or diagnostic services, health providers should contact their state health department TB
control officers to apprise them of the need for follow-up and of the next possible destination of the
farm worker. 
Out-of-state communications regarding TB care should be routed through state health departments
to ensure that the information is transmitted appropriately and that necessary follow-up is initiated.
Often the health-care provider or health department will receive a TB laboratory report after the
9 of 12
Prevention and Control of TB in Migrant Farm Workers Recom. of ACET
person departs for another area. The report should be immediately telephoned or expeditiously
mailed to the health department or health-care provider in the next area. 
Although sharing necessary information between health-care providers and health departments is
encouraged to protect the health of the worker and the public, information should be shared only on
a need-to-know basis. Measures must be taken to ensure confidentiality. 
Migrants who are placed on antituberculosis treatment or preventive therapy should be given
records they can take with them to indicate their current treatment and diagnostic status. Special
care should be taken to instruct such persons on how to take their medications and how and where
to get additional medication and medical care at the destination sites. 
Different areas have different protocols for the treatment of active TB and for the preventive
treatment of infected persons. However, once a patient starts treatment or a preventive treatment
regimen, the same regimen should be continued in the migrant's next location (unless medically
contraindicated). 
Role of Public Health Departments 
Health departments should ensure the provision of TB services for migrant and seasonal farm
workers regardless of ability to pay. These services should include diagnostic services,
antituberculosis medication, laboratory services, contact follow-up and inpatient and outpatient
clinical services. Making medical care accessible to the migrant farm workers and their families
often means providing services in migrant health-care centers or near the work site. Health
departments should make outreach services available for directly observed therapy. 
Health departments should ensure that expert TB medical consultation is available to the clinicians
and nurses providing health-care services to migrant farm workers. 
Health departments should teach migrant health personnel how to perform and read intracutaneous
Mantoux tuberculin tests. To aid in this training, CDC has made training materials available through
state health departments. 
Whenever possible, physicians and nurses from the migrant health centers should be invited to
attend state and local health department TB control staff training programs. 
Role of the Public Health Service 
The Public Health Service (PHS) should promote collaboration between health departments and
migrant health centers in the homebase states and elsewhere to plan and carry out TB screening and
preventive therapy programs. The PHS should require documentation of such collaboration as part
of applications for federally funded migrant health and TB grants and cooperative agreements. In
addition, as part of routine site visits, PHS staff should review related activities and make proposals
for more effective implementation of the recommendations in this document. 
The CDC and the Health Resources and Services Administration, with the assistance of the Migrant
Clinicians Network, should jointly develop a prototype TB medical history card to be given to
migrant workers. The card should indicate results of the worker's latest tuberculin test, history of
preventive therapy, and appropriate current and past treatment and diagnostic status. This card can
serve as a supplement to, but cannot substitute for, complete medical records 
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Full implementation will require the commitment of additional resources at the national, state and local
levels. Implementation of these recommendations is an important step in the TB elimination effort. Most
importantly, implementation of these recommendations will be of great benefit to individual migrant farm
workers and their families whose economic and social progress is being impeded by the occurrence of TB.
For further information on TB diagnosis, treatment, monitoring, and control the following references are
recommended: 
Treatment of Tuberculosis and Tuberculosis Infection in Adults and Children, American Review of
Respiratory Disease, 1986;134(2):355-63. 
Diagnostic Standards and Classification of Tuberculosis 1990, American Review of Respiratory
Diseases, 1990;142(3):725-35. 
Control of Tuberculosis in the United States, American Review of Respiratory Diseases, 1992 (in
press). 
Core Curriculum on Tuberculosis, developed by the American Thoracic Society and CDC and
supported by a grant from the Pittsfield AntiTuberculosis Association. 
Improving Patient Compliance, CDC, revised February, 1990. Reprints are available from either
state or local health departments or from American Lung Association offices. 
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